|
| Ana Osorio | University of Cambridge, MRC Institute of Genetics and Molecular Medicine (A. Campbell, University of Edinburgh, University of Edinburgh Medical School (A. Campbell, Health Services Research, University of Manchester, the NIHR Manchester Biomedical Research Unit (E.F.H.) and the Nightingale Breast Screening Centre, Wythenshawe Hospital (E.F.H., St. Mary's Hospital, Manchester University NHS Foundation Trust (W.G.N., the School of Cancer and Pharmaceutical Sciences, Comprehensive Cancer Centre, King's College London, the Institute of Cancer and Genomic Sciences, University of Birmingham, and the Wellcome Trust Centre for Human Genetics and Oxford NIHR Biomedical Research Centre, University of Oxford, Spanish National Cancer Research Center, Hospital Universitario La Paz (M.P.Z.), Hospital Clinico San Carlos, Instituto de Investigacion Sanitaria del Hospital Clinico San Carlos (M. de la Hoya), Galician Foundation of Genomic Medicine, Instituto de Investigacion Sanitaria de Santiago de Co |
| Sabine Behrens | University of Cambridge, MRC Institute of Genetics and Molecular Medicine (A. Campbell, University of Edinburgh, University of Edinburgh Medical School (A. Campbell, Health Services Research, University of Manchester, the NIHR Manchester Biomedical Research Unit (E.F.H.) and the Nightingale Breast Screening Centre, Wythenshawe Hospital (E.F.H., St. Mary's Hospital, Manchester University NHS Foundation Trust (W.G.N., the School of Cancer and Pharmaceutical Sciences, Comprehensive Cancer Centre, King's College London, the Institute of Cancer and Genomic Sciences, University of Birmingham, and the Wellcome Trust Centre for Human Genetics and Oxford NIHR Biomedical Research Centre, University of Oxford, Spanish National Cancer Research Center, Hospital Universitario La Paz (M.P.Z.), Hospital Clinico San Carlos, Instituto de Investigacion Sanitaria del Hospital Clinico San Carlos (M. de la Hoya), Galician Foundation of Genomic Medicine, Instituto de Investigacion Sanitaria de Santiago de Co |
| Anne-Lise B??rresen-Dale | University of Cambridge, MRC Institute of Genetics and Molecular Medicine (A. Campbell, University of Edinburgh, University of Edinburgh Medical School (A. Campbell, Health Services Research, University of Manchester, the NIHR Manchester Biomedical Research Unit (E.F.H.) and the Nightingale Breast Screening Centre, Wythenshawe Hospital (E.F.H., St. Mary's Hospital, Manchester University NHS Foundation Trust (W.G.N., the School of Cancer and Pharmaceutical Sciences, Comprehensive Cancer Centre, King's College London, the Institute of Cancer and Genomic Sciences, University of Birmingham, and the Wellcome Trust Centre for Human Genetics and Oxford NIHR Biomedical Research Centre, University of Oxford, Spanish National Cancer Research Center, Hospital Universitario La Paz (M.P.Z.), Hospital Clinico San Carlos, Instituto de Investigacion Sanitaria del Hospital Clinico San Carlos (M. de la Hoya), Galician Foundation of Genomic Medicine, Instituto de Investigacion Sanitaria de Santiago de Co |
| Anne-Lise B??rresen-Dale | University of Cambridge, MRC Institute of Genetics and Molecular Medicine (A. Campbell, University of Edinburgh, University of Edinburgh Medical School (A. Campbell, Health Services Research, University of Manchester, the NIHR Manchester Biomedical Research Unit (E.F.H.) and the Nightingale Breast Screening Centre, Wythenshawe Hospital (E.F.H., St. Mary's Hospital, Manchester University NHS Foundation Trust (W.G.N., the School of Cancer and Pharmaceutical Sciences, Comprehensive Cancer Centre, King's College London, the Institute of Cancer and Genomic Sciences, University of Birmingham, and the Wellcome Trust Centre for Human Genetics and Oxford NIHR Biomedical Research Centre, University of Oxford, Spanish National Cancer Research Center, Hospital Universitario La Paz (M.P.Z.), Hospital Clinico San Carlos, Instituto de Investigacion Sanitaria del Hospital Clinico San Carlos (M. de la Hoya), Galician Foundation of Genomic Medicine, Instituto de Investigacion Sanitaria de Santiago de Co |
| Angel Carracedo | University of Cambridge, MRC Institute of Genetics and Molecular Medicine (A. Campbell, University of Edinburgh, University of Edinburgh Medical School (A. Campbell, Health Services Research, University of Manchester, the NIHR Manchester Biomedical Research Unit (E.F.H.) and the Nightingale Breast Screening Centre, Wythenshawe Hospital (E.F.H., St. Mary's Hospital, Manchester University NHS Foundation Trust (W.G.N., the School of Cancer and Pharmaceutical Sciences, Comprehensive Cancer Centre, King's College London, the Institute of Cancer and Genomic Sciences, University of Birmingham, and the Wellcome Trust Centre for Human Genetics and Oxford NIHR Biomedical Research Centre, University of Oxford, Spanish National Cancer Research Center, Hospital Universitario La Paz (M.P.Z.), Hospital Clinico San Carlos, Instituto de Investigacion Sanitaria del Hospital Clinico San Carlos (M. de la Hoya), Galician Foundation of Genomic Medicine, Instituto de Investigacion Sanitaria de Santiago de Co |
| Melissa H Cessna | University of Cambridge, MRC Institute of Genetics and Molecular Medicine (A. Campbell, University of Edinburgh, University of Edinburgh Medical School (A. Campbell, Health Services Research, University of Manchester, the NIHR Manchester Biomedical Research Unit (E.F.H.) and the Nightingale Breast Screening Centre, Wythenshawe Hospital (E.F.H., St. Mary's Hospital, Manchester University NHS Foundation Trust (W.G.N., the School of Cancer and Pharmaceutical Sciences, Comprehensive Cancer Centre, King's College London, the Institute of Cancer and Genomic Sciences, University of Birmingham, and the Wellcome Trust Centre for Human Genetics and Oxford NIHR Biomedical Research Centre, University of Oxford, Spanish National Cancer Research Center, Hospital Universitario La Paz (M.P.Z.), Hospital Clinico San Carlos, Instituto de Investigacion Sanitaria del Hospital Clinico San Carlos (M. de la Hoya), Galician Foundation of Genomic Medicine, Instituto de Investigacion Sanitaria de Santiago de Co |
| Stephen J Chanock | University of Cambridge, MRC Institute of Genetics and Molecular Medicine (A. Campbell, University of Edinburgh, University of Edinburgh Medical School (A. Campbell, Health Services Research, University of Manchester, the NIHR Manchester Biomedical Research Unit (E.F.H.) and the Nightingale Breast Screening Centre, Wythenshawe Hospital (E.F.H., St. Mary's Hospital, Manchester University NHS Foundation Trust (W.G.N., the School of Cancer and Pharmaceutical Sciences, Comprehensive Cancer Centre, King's College London, the Institute of Cancer and Genomic Sciences, University of Birmingham, and the Wellcome Trust Centre for Human Genetics and Oxford NIHR Biomedical Research Centre, University of Oxford, Spanish National Cancer Research Center, Hospital Universitario La Paz (M.P.Z.), Hospital Clinico San Carlos, Instituto de Investigacion Sanitaria del Hospital Clinico San Carlos (M. de la Hoya), Galician Foundation of Genomic Medicine, Instituto de Investigacion Sanitaria de Santiago de Co |
| Stephen J Chanock | University of Cambridge, MRC Institute of Genetics and Molecular Medicine (A. Campbell, University of Edinburgh, University of Edinburgh Medical School (A. Campbell, Health Services Research, University of Manchester, the NIHR Manchester Biomedical Research Unit (E.F.H.) and the Nightingale Breast Screening Centre, Wythenshawe Hospital (E.F.H., St. Mary's Hospital, Manchester University NHS Foundation Trust (W.G.N., the School of Cancer and Pharmaceutical Sciences, Comprehensive Cancer Centre, King's College London, the Institute of Cancer and Genomic Sciences, University of Birmingham, and the Wellcome Trust Centre for Human Genetics and Oxford NIHR Biomedical Research Centre, University of Oxford, Spanish National Cancer Research Center, Hospital Universitario La Paz (M.P.Z.), Hospital Clinico San Carlos, Instituto de Investigacion Sanitaria del Hospital Clinico San Carlos (M. de la Hoya), Galician Foundation of Genomic Medicine, Instituto de Investigacion Sanitaria de Santiago de Co |
| Peter A Fasching | University of Cambridge, MRC Institute of Genetics and Molecular Medicine (A. Campbell, University of Edinburgh, University of Edinburgh Medical School (A. Campbell, Health Services Research, University of Manchester, the NIHR Manchester Biomedical Research Unit (E.F.H.) and the Nightingale Breast Screening Centre, Wythenshawe Hospital (E.F.H., St. Mary's Hospital, Manchester University NHS Foundation Trust (W.G.N., the School of Cancer and Pharmaceutical Sciences, Comprehensive Cancer Centre, King's College London, the Institute of Cancer and Genomic Sciences, University of Birmingham, and the Wellcome Trust Centre for Human Genetics and Oxford NIHR Biomedical Research Centre, University of Oxford, Spanish National Cancer Research Center, Hospital Universitario La Paz (M.P.Z.), Hospital Clinico San Carlos, Instituto de Investigacion Sanitaria del Hospital Clinico San Carlos (M. de la Hoya), Galician Foundation of Genomic Medicine, Instituto de Investigacion Sanitaria de Santiago de Co |
| Jonine D Figueroa | University of Cambridge, MRC Institute of Genetics and Molecular Medicine (A. Campbell, University of Edinburgh, University of Edinburgh Medical School (A. Campbell, Health Services Research, University of Manchester, the NIHR Manchester Biomedical Research Unit (E.F.H.) and the Nightingale Breast Screening Centre, Wythenshawe Hospital (E.F.H., St. Mary's Hospital, Manchester University NHS Foundation Trust (W.G.N., the School of Cancer and Pharmaceutical Sciences, Comprehensive Cancer Centre, King's College London, the Institute of Cancer and Genomic Sciences, University of Birmingham, and the Wellcome Trust Centre for Human Genetics and Oxford NIHR Biomedical Research Centre, University of Oxford, Spanish National Cancer Research Center, Hospital Universitario La Paz (M.P.Z.), Hospital Clinico San Carlos, Instituto de Investigacion Sanitaria del Hospital Clinico San Carlos (M. de la Hoya), Galician Foundation of Genomic Medicine, Instituto de Investigacion Sanitaria de Santiago de Co |
| Jonine D Figueroa | University of Cambridge, MRC Institute of Genetics and Molecular Medicine (A. Campbell, University of Edinburgh, University of Edinburgh Medical School (A. Campbell, Health Services Research, University of Manchester, the NIHR Manchester Biomedical Research Unit (E.F.H.) and the Nightingale Breast Screening Centre, Wythenshawe Hospital (E.F.H., St. Mary's Hospital, Manchester University NHS Foundation Trust (W.G.N., the School of Cancer and Pharmaceutical Sciences, Comprehensive Cancer Centre, King's College London, the Institute of Cancer and Genomic Sciences, University of Birmingham, and the Wellcome Trust Centre for Human Genetics and Oxford NIHR Biomedical Research Centre, University of Oxford, Spanish National Cancer Research Center, Hospital Universitario La Paz (M.P.Z.), Hospital Clinico San Carlos, Instituto de Investigacion Sanitaria del Hospital Clinico San Carlos (M. de la Hoya), Galician Foundation of Genomic Medicine, Instituto de Investigacion Sanitaria de Santiago de Co |
| Graham G Giles | University of Cambridge, MRC Institute of Genetics and Molecular Medicine (A. Campbell, University of Edinburgh, University of Edinburgh Medical School (A. Campbell, Health Services Research, University of Manchester, the NIHR Manchester Biomedical Research Unit (E.F.H.) and the Nightingale Breast Screening Centre, Wythenshawe Hospital (E.F.H., St. Mary's Hospital, Manchester University NHS Foundation Trust (W.G.N., the School of Cancer and Pharmaceutical Sciences, Comprehensive Cancer Centre, King's College London, the Institute of Cancer and Genomic Sciences, University of Birmingham, and the Wellcome Trust Centre for Human Genetics and Oxford NIHR Biomedical Research Centre, University of Oxford, Spanish National Cancer Research Center, Hospital Universitario La Paz (M.P.Z.), Hospital Clinico San Carlos, Instituto de Investigacion Sanitaria del Hospital Clinico San Carlos (M. de la Hoya), Galician Foundation of Genomic Medicine, Instituto de Investigacion Sanitaria de Santiago de Co |
| Per Hall | University of Cambridge, MRC Institute of Genetics and Molecular Medicine (A. Campbell, University of Edinburgh, University of Edinburgh Medical School (A. Campbell, Health Services Research, University of Manchester, the NIHR Manchester Biomedical Research Unit (E.F.H.) and the Nightingale Breast Screening Centre, Wythenshawe Hospital (E.F.H., St. Mary's Hospital, Manchester University NHS Foundation Trust (W.G.N., the School of Cancer and Pharmaceutical Sciences, Comprehensive Cancer Centre, King's College London, the Institute of Cancer and Genomic Sciences, University of Birmingham, and the Wellcome Trust Centre for Human Genetics and Oxford NIHR Biomedical Research Centre, University of Oxford, Spanish National Cancer Research Center, Hospital Universitario La Paz (M.P.Z.), Hospital Clinico San Carlos, Instituto de Investigacion Sanitaria del Hospital Clinico San Carlos (M. de la Hoya), Galician Foundation of Genomic Medicine, Instituto de Investigacion Sanitaria de Santiago de Co |
| Vessela N Kristensen | University of Cambridge, MRC Institute of Genetics and Molecular Medicine (A. Campbell, University of Edinburgh, University of Edinburgh Medical School (A. Campbell, Health Services Research, University of Manchester, the NIHR Manchester Biomedical Research Unit (E.F.H.) and the Nightingale Breast Screening Centre, Wythenshawe Hospital (E.F.H., St. Mary's Hospital, Manchester University NHS Foundation Trust (W.G.N., the School of Cancer and Pharmaceutical Sciences, Comprehensive Cancer Centre, King's College London, the Institute of Cancer and Genomic Sciences, University of Birmingham, and the Wellcome Trust Centre for Human Genetics and Oxford NIHR Biomedical Research Centre, University of Oxford, Spanish National Cancer Research Center, Hospital Universitario La Paz (M.P.Z.), Hospital Clinico San Carlos, Instituto de Investigacion Sanitaria del Hospital Clinico San Carlos (M. de la Hoya), Galician Foundation of Genomic Medicine, Instituto de Investigacion Sanitaria de Santiago de Co |
| Jeong-Won Lee | University of Cambridge, MRC Institute of Genetics and Molecular Medicine (A. Campbell, University of Edinburgh, University of Edinburgh Medical School (A. Campbell, Health Services Research, University of Manchester, the NIHR Manchester Biomedical Research Unit (E.F.H.) and the Nightingale Breast Screening Centre, Wythenshawe Hospital (E.F.H., St. Mary's Hospital, Manchester University NHS Foundation Trust (W.G.N., the School of Cancer and Pharmaceutical Sciences, Comprehensive Cancer Centre, King's College London, the Institute of Cancer and Genomic Sciences, University of Birmingham, and the Wellcome Trust Centre for Human Genetics and Oxford NIHR Biomedical Research Centre, University of Oxford, Spanish National Cancer Research Center, Hospital Universitario La Paz (M.P.Z.), Hospital Clinico San Carlos, Instituto de Investigacion Sanitaria del Hospital Clinico San Carlos (M. de la Hoya), Galician Foundation of Genomic Medicine, Instituto de Investigacion Sanitaria de Santiago de Co |
| Jan Lubinski | University of Cambridge, MRC Institute of Genetics and Molecular Medicine (A. Campbell, University of Edinburgh, University of Edinburgh Medical School (A. Campbell, Health Services Research, University of Manchester, the NIHR Manchester Biomedical Research Unit (E.F.H.) and the Nightingale Breast Screening Centre, Wythenshawe Hospital (E.F.H., St. Mary's Hospital, Manchester University NHS Foundation Trust (W.G.N., the School of Cancer and Pharmaceutical Sciences, Comprehensive Cancer Centre, King's College London, the Institute of Cancer and Genomic Sciences, University of Birmingham, and the Wellcome Trust Centre for Human Genetics and Oxford NIHR Biomedical Research Centre, University of Oxford, Spanish National Cancer Research Center, Hospital Universitario La Paz (M.P.Z.), Hospital Clinico San Carlos, Instituto de Investigacion Sanitaria del Hospital Clinico San Carlos (M. de la Hoya), Galician Foundation of Genomic Medicine, Instituto de Investigacion Sanitaria de Santiago de Co |
| Jan Lubinski | University of Cambridge, MRC Institute of Genetics and Molecular Medicine (A. Campbell, University of Edinburgh, University of Edinburgh Medical School (A. Campbell, Health Services Research, University of Manchester, the NIHR Manchester Biomedical Research Unit (E.F.H.) and the Nightingale Breast Screening Centre, Wythenshawe Hospital (E.F.H., St. Mary's Hospital, Manchester University NHS Foundation Trust (W.G.N., the School of Cancer and Pharmaceutical Sciences, Comprehensive Cancer Centre, King's College London, the Institute of Cancer and Genomic Sciences, University of Birmingham, and the Wellcome Trust Centre for Human Genetics and Oxford NIHR Biomedical Research Centre, University of Oxford, Spanish National Cancer Research Center, Hospital Universitario La Paz (M.P.Z.), Hospital Clinico San Carlos, Instituto de Investigacion Sanitaria del Hospital Clinico San Carlos (M. de la Hoya), Galician Foundation of Genomic Medicine, Instituto de Investigacion Sanitaria de Santiago de Co |
| Siranoush Manoukian | University of Cambridge, MRC Institute of Genetics and Molecular Medicine (A. Campbell, University of Edinburgh, University of Edinburgh Medical School (A. Campbell, Health Services Research, University of Manchester, the NIHR Manchester Biomedical Research Unit (E.F.H.) and the Nightingale Breast Screening Centre, Wythenshawe Hospital (E.F.H., St. Mary's Hospital, Manchester University NHS Foundation Trust (W.G.N., the School of Cancer and Pharmaceutical Sciences, Comprehensive Cancer Centre, King's College London, the Institute of Cancer and Genomic Sciences, University of Birmingham, and the Wellcome Trust Centre for Human Genetics and Oxford NIHR Biomedical Research Centre, University of Oxford, Spanish National Cancer Research Center, Hospital Universitario La Paz (M.P.Z.), Hospital Clinico San Carlos, Instituto de Investigacion Sanitaria del Hospital Clinico San Carlos (M. de la Hoya), Galician Foundation of Genomic Medicine, Instituto de Investigacion Sanitaria de Santiago de Co |
| Maria Elena Martinez | University of Cambridge, MRC Institute of Genetics and Molecular Medicine (A. Campbell, University of Edinburgh, University of Edinburgh Medical School (A. Campbell, Health Services Research, University of Manchester, the NIHR Manchester Biomedical Research Unit (E.F.H.) and the Nightingale Breast Screening Centre, Wythenshawe Hospital (E.F.H., St. Mary's Hospital, Manchester University NHS Foundation Trust (W.G.N., the School of Cancer and Pharmaceutical Sciences, Comprehensive Cancer Centre, King's College London, the Institute of Cancer and Genomic Sciences, University of Birmingham, and the Wellcome Trust Centre for Human Genetics and Oxford NIHR Biomedical Research Centre, University of Oxford, Spanish National Cancer Research Center, Hospital Universitario La Paz (M.P.Z.), Hospital Clinico San Carlos, Instituto de Investigacion Sanitaria del Hospital Clinico San Carlos (M. de la Hoya), Galician Foundation of Genomic Medicine, Instituto de Investigacion Sanitaria de Santiago de Co |
| Børge G Nordestgaard | University of Cambridge, MRC Institute of Genetics and Molecular Medicine (A. Campbell, University of Edinburgh, University of Edinburgh Medical School (A. Campbell, Health Services Research, University of Manchester, the NIHR Manchester Biomedical Research Unit (E.F.H.) and the Nightingale Breast Screening Centre, Wythenshawe Hospital (E.F.H., St. Mary's Hospital, Manchester University NHS Foundation Trust (W.G.N., the School of Cancer and Pharmaceutical Sciences, Comprehensive Cancer Centre, King's College London, the Institute of Cancer and Genomic Sciences, University of Birmingham, and the Wellcome Trust Centre for Human Genetics and Oxford NIHR Biomedical Research Centre, University of Oxford, Spanish National Cancer Research Center, Hospital Universitario La Paz (M.P.Z.), Hospital Clinico San Carlos, Instituto de Investigacion Sanitaria del Hospital Clinico San Carlos (M. de la Hoya), Galician Foundation of Genomic Medicine, Instituto de Investigacion Sanitaria de Santiago de Co |
| Paolo Radice | University of Cambridge, MRC Institute of Genetics and Molecular Medicine (A. Campbell, University of Edinburgh, University of Edinburgh Medical School (A. Campbell, Health Services Research, University of Manchester, the NIHR Manchester Biomedical Research Unit (E.F.H.) and the Nightingale Breast Screening Centre, Wythenshawe Hospital (E.F.H., St. Mary's Hospital, Manchester University NHS Foundation Trust (W.G.N., the School of Cancer and Pharmaceutical Sciences, Comprehensive Cancer Centre, King's College London, the Institute of Cancer and Genomic Sciences, University of Birmingham, and the Wellcome Trust Centre for Human Genetics and Oxford NIHR Biomedical Research Centre, University of Oxford, Spanish National Cancer Research Center, Hospital Universitario La Paz (M.P.Z.), Hospital Clinico San Carlos, Instituto de Investigacion Sanitaria del Hospital Clinico San Carlos (M. de la Hoya), Galician Foundation of Genomic Medicine, Instituto de Investigacion Sanitaria de Santiago de Co |
| Valerie Rhenius | University of Cambridge, MRC Institute of Genetics and Molecular Medicine (A. Campbell, University of Edinburgh, University of Edinburgh Medical School (A. Campbell, Health Services Research, University of Manchester, the NIHR Manchester Biomedical Research Unit (E.F.H.) and the Nightingale Breast Screening Centre, Wythenshawe Hospital (E.F.H., St. Mary's Hospital, Manchester University NHS Foundation Trust (W.G.N., the School of Cancer and Pharmaceutical Sciences, Comprehensive Cancer Centre, King's College London, the Institute of Cancer and Genomic Sciences, University of Birmingham, and the Wellcome Trust Centre for Human Genetics and Oxford NIHR Biomedical Research Centre, University of Oxford, Spanish National Cancer Research Center, Hospital Universitario La Paz (M.P.Z.), Hospital Clinico San Carlos, Instituto de Investigacion Sanitaria del Hospital Clinico San Carlos (M. de la Hoya), Galician Foundation of Genomic Medicine, Instituto de Investigacion Sanitaria de Santiago de Co |
| Christi J van Asperen | University of Cambridge, MRC Institute of Genetics and Molecular Medicine (A. Campbell, University of Edinburgh, University of Edinburgh Medical School (A. Campbell, Health Services Research, University of Manchester, the NIHR Manchester Biomedical Research Unit (E.F.H.) and the Nightingale Breast Screening Centre, Wythenshawe Hospital (E.F.H., St. Mary's Hospital, Manchester University NHS Foundation Trust (W.G.N., the School of Cancer and Pharmaceutical Sciences, Comprehensive Cancer Centre, King's College London, the Institute of Cancer and Genomic Sciences, University of Birmingham, and the Wellcome Trust Centre for Human Genetics and Oxford NIHR Biomedical Research Centre, University of Oxford, Spanish National Cancer Research Center, Hospital Universitario La Paz (M.P.Z.), Hospital Clinico San Carlos, Instituto de Investigacion Sanitaria del Hospital Clinico San Carlos (M. de la Hoya), Galician Foundation of Genomic Medicine, Instituto de Investigacion Sanitaria de Santiago de Co |
| Rob M van Dam | University of Cambridge, MRC Institute of Genetics and Molecular Medicine (A. Campbell, University of Edinburgh, University of Edinburgh Medical School (A. Campbell, Health Services Research, University of Manchester, the NIHR Manchester Biomedical Research Unit (E.F.H.) and the Nightingale Breast Screening Centre, Wythenshawe Hospital (E.F.H., St. Mary's Hospital, Manchester University NHS Foundation Trust (W.G.N., the School of Cancer and Pharmaceutical Sciences, Comprehensive Cancer Centre, King's College London, the Institute of Cancer and Genomic Sciences, University of Birmingham, and the Wellcome Trust Centre for Human Genetics and Oxford NIHR Biomedical Research Centre, University of Oxford, Spanish National Cancer Research Center, Hospital Universitario La Paz (M.P.Z.), Hospital Clinico San Carlos, Instituto de Investigacion Sanitaria del Hospital Clinico San Carlos (M. de la Hoya), Galician Foundation of Genomic Medicine, Instituto de Investigacion Sanitaria de Santiago de Co |
| Xiaohong R Yang | University of Cambridge, MRC Institute of Genetics and Molecular Medicine (A. Campbell, University of Edinburgh, University of Edinburgh Medical School (A. Campbell, Health Services Research, University of Manchester, the NIHR Manchester Biomedical Research Unit (E.F.H.) and the Nightingale Breast Screening Centre, Wythenshawe Hospital (E.F.H., St. Mary's Hospital, Manchester University NHS Foundation Trust (W.G.N., the School of Cancer and Pharmaceutical Sciences, Comprehensive Cancer Centre, King's College London, the Institute of Cancer and Genomic Sciences, University of Birmingham, and the Wellcome Trust Centre for Human Genetics and Oxford NIHR Biomedical Research Centre, University of Oxford, Spanish National Cancer Research Center, Hospital Universitario La Paz (M.P.Z.), Hospital Clinico San Carlos, Instituto de Investigacion Sanitaria del Hospital Clinico San Carlos (M. de la Hoya), Galician Foundation of Genomic Medicine, Instituto de Investigacion Sanitaria de Santiago de Co |
| Xiaohong R Yang | University of Cambridge, MRC Institute of Genetics and Molecular Medicine (A. Campbell, University of Edinburgh, University of Edinburgh Medical School (A. Campbell, Health Services Research, University of Manchester, the NIHR Manchester Biomedical Research Unit (E.F.H.) and the Nightingale Breast Screening Centre, Wythenshawe Hospital (E.F.H., St. Mary's Hospital, Manchester University NHS Foundation Trust (W.G.N., the School of Cancer and Pharmaceutical Sciences, Comprehensive Cancer Centre, King's College London, the Institute of Cancer and Genomic Sciences, University of Birmingham, and the Wellcome Trust Centre for Human Genetics and Oxford NIHR Biomedical Research Centre, University of Oxford, Spanish National Cancer Research Center, Hospital Universitario La Paz (M.P.Z.), Hospital Clinico San Carlos, Instituto de Investigacion Sanitaria del Hospital Clinico San Carlos (M. de la Hoya), Galician Foundation of Genomic Medicine, Instituto de Investigacion Sanitaria de Santiago de Co |
| Irene L Andrulis | University of Cambridge, MRC Institute of Genetics and Molecular Medicine (A. Campbell, University of Edinburgh, University of Edinburgh Medical School (A. Campbell, Health Services Research, University of Manchester, the NIHR Manchester Biomedical Research Unit (E.F.H.) and the Nightingale Breast Screening Centre, Wythenshawe Hospital (E.F.H., St. Mary's Hospital, Manchester University NHS Foundation Trust (W.G.N., the School of Cancer and Pharmaceutical Sciences, Comprehensive Cancer Centre, King's College London, the Institute of Cancer and Genomic Sciences, University of Birmingham, and the Wellcome Trust Centre for Human Genetics and Oxford NIHR Biomedical Research Centre, University of Oxford, Spanish National Cancer Research Center, Hospital Universitario La Paz (M.P.Z.), Hospital Clinico San Carlos, Instituto de Investigacion Sanitaria del Hospital Clinico San Carlos (M. de la Hoya), Galician Foundation of Genomic Medicine, Instituto de Investigacion Sanitaria de Santiago de Co |
| Irene L Andrulis | University of Cambridge, MRC Institute of Genetics and Molecular Medicine (A. Campbell, University of Edinburgh, University of Edinburgh Medical School (A. Campbell, Health Services Research, University of Manchester, the NIHR Manchester Biomedical Research Unit (E.F.H.) and the Nightingale Breast Screening Centre, Wythenshawe Hospital (E.F.H., St. Mary's Hospital, Manchester University NHS Foundation Trust (W.G.N., the School of Cancer and Pharmaceutical Sciences, Comprehensive Cancer Centre, King's College London, the Institute of Cancer and Genomic Sciences, University of Birmingham, and the Wellcome Trust Centre for Human Genetics and Oxford NIHR Biomedical Research Centre, University of Oxford, Spanish National Cancer Research Center, Hospital Universitario La Paz (M.P.Z.), Hospital Clinico San Carlos, Instituto de Investigacion Sanitaria del Hospital Clinico San Carlos (M. de la Hoya), Galician Foundation of Genomic Medicine, Instituto de Investigacion Sanitaria de Santiago de Co |
| Jenny Chang-Claude | University of Cambridge, MRC Institute of Genetics and Molecular Medicine (A. Campbell, University of Edinburgh, University of Edinburgh Medical School (A. Campbell, Health Services Research, University of Manchester, the NIHR Manchester Biomedical Research Unit (E.F.H.) and the Nightingale Breast Screening Centre, Wythenshawe Hospital (E.F.H., St. Mary's Hospital, Manchester University NHS Foundation Trust (W.G.N., the School of Cancer and Pharmaceutical Sciences, Comprehensive Cancer Centre, King's College London, the Institute of Cancer and Genomic Sciences, University of Birmingham, and the Wellcome Trust Centre for Human Genetics and Oxford NIHR Biomedical Research Centre, University of Oxford, Spanish National Cancer Research Center, Hospital Universitario La Paz (M.P.Z.), Hospital Clinico San Carlos, Instituto de Investigacion Sanitaria del Hospital Clinico San Carlos (M. de la Hoya), Galician Foundation of Genomic Medicine, Instituto de Investigacion Sanitaria de Santiago de Co |
| Montserrat Garcia-Closas | University of Cambridge, MRC Institute of Genetics and Molecular Medicine (A. Campbell, University of Edinburgh, University of Edinburgh Medical School (A. Campbell, Health Services Research, University of Manchester, the NIHR Manchester Biomedical Research Unit (E.F.H.) and the Nightingale Breast Screening Centre, Wythenshawe Hospital (E.F.H., St. Mary's Hospital, Manchester University NHS Foundation Trust (W.G.N., the School of Cancer and Pharmaceutical Sciences, Comprehensive Cancer Centre, King's College London, the Institute of Cancer and Genomic Sciences, University of Birmingham, and the Wellcome Trust Centre for Human Genetics and Oxford NIHR Biomedical Research Centre, University of Oxford, Spanish National Cancer Research Center, Hospital Universitario La Paz (M.P.Z.), Hospital Clinico San Carlos, Instituto de Investigacion Sanitaria del Hospital Clinico San Carlos (M. de la Hoya), Galician Foundation of Genomic Medicine, Instituto de Investigacion Sanitaria de Santiago de Co |
| Montserrat Garcia-Closas | University of Cambridge, MRC Institute of Genetics and Molecular Medicine (A. Campbell, University of Edinburgh, University of Edinburgh Medical School (A. Campbell, Health Services Research, University of Manchester, the NIHR Manchester Biomedical Research Unit (E.F.H.) and the Nightingale Breast Screening Centre, Wythenshawe Hospital (E.F.H., St. Mary's Hospital, Manchester University NHS Foundation Trust (W.G.N., the School of Cancer and Pharmaceutical Sciences, Comprehensive Cancer Centre, King's College London, the Institute of Cancer and Genomic Sciences, University of Birmingham, and the Wellcome Trust Centre for Human Genetics and Oxford NIHR Biomedical Research Centre, University of Oxford, Spanish National Cancer Research Center, Hospital Universitario La Paz (M.P.Z.), Hospital Clinico San Carlos, Instituto de Investigacion Sanitaria del Hospital Clinico San Carlos (M. de la Hoya), Galician Foundation of Genomic Medicine, Instituto de Investigacion Sanitaria de Santiago de Co |
| Georgia Chenevix-Trench | University of Cambridge, MRC Institute of Genetics and Molecular Medicine (A. Campbell, University of Edinburgh, University of Edinburgh Medical School (A. Campbell, Health Services Research, University of Manchester, the NIHR Manchester Biomedical Research Unit (E.F.H.) and the Nightingale Breast Screening Centre, Wythenshawe Hospital (E.F.H., St. Mary's Hospital, Manchester University NHS Foundation Trust (W.G.N., the School of Cancer and Pharmaceutical Sciences, Comprehensive Cancer Centre, King's College London, the Institute of Cancer and Genomic Sciences, University of Birmingham, and the Wellcome Trust Centre for Human Genetics and Oxford NIHR Biomedical Research Centre, University of Oxford, Spanish National Cancer Research Center, Hospital Universitario La Paz (M.P.Z.), Hospital Clinico San Carlos, Instituto de Investigacion Sanitaria del Hospital Clinico San Carlos (M. de la Hoya), Galician Foundation of Genomic Medicine, Instituto de Investigacion Sanitaria de Santiago de Co |
| Georgia Chenevix-Trench | University of Cambridge, MRC Institute of Genetics and Molecular Medicine (A. Campbell, University of Edinburgh, University of Edinburgh Medical School (A. Campbell, Health Services Research, University of Manchester, the NIHR Manchester Biomedical Research Unit (E.F.H.) and the Nightingale Breast Screening Centre, Wythenshawe Hospital (E.F.H., St. Mary's Hospital, Manchester University NHS Foundation Trust (W.G.N., the School of Cancer and Pharmaceutical Sciences, Comprehensive Cancer Centre, King's College London, the Institute of Cancer and Genomic Sciences, University of Birmingham, and the Wellcome Trust Centre for Human Genetics and Oxford NIHR Biomedical Research Centre, University of Oxford, Spanish National Cancer Research Center, Hospital Universitario La Paz (M.P.Z.), Hospital Clinico San Carlos, Instituto de Investigacion Sanitaria del Hospital Clinico San Carlos (M. de la Hoya), Galician Foundation of Genomic Medicine, Instituto de Investigacion Sanitaria de Santiago de Co |
| Roger L Milne | University of Cambridge, MRC Institute of Genetics and Molecular Medicine (A. Campbell, University of Edinburgh, University of Edinburgh Medical School (A. Campbell, Health Services Research, University of Manchester, the NIHR Manchester Biomedical Research Unit (E.F.H.) and the Nightingale Breast Screening Centre, Wythenshawe Hospital (E.F.H., St. Mary's Hospital, Manchester University NHS Foundation Trust (W.G.N., the School of Cancer and Pharmaceutical Sciences, Comprehensive Cancer Centre, King's College London, the Institute of Cancer and Genomic Sciences, University of Birmingham, and the Wellcome Trust Centre for Human Genetics and Oxford NIHR Biomedical Research Centre, University of Oxford, Spanish National Cancer Research Center, Hospital Universitario La Paz (M.P.Z.), Hospital Clinico San Carlos, Instituto de Investigacion Sanitaria del Hospital Clinico San Carlos (M. de la Hoya), Galician Foundation of Genomic Medicine, Instituto de Investigacion Sanitaria de Santiago de Co |
| Paul D P Pharoah | University of Cambridge, MRC Institute of Genetics and Molecular Medicine (A. Campbell, University of Edinburgh, University of Edinburgh Medical School (A. Campbell, Health Services Research, University of Manchester, the NIHR Manchester Biomedical Research Unit (E.F.H.) and the Nightingale Breast Screening Centre, Wythenshawe Hospital (E.F.H., St. Mary's Hospital, Manchester University NHS Foundation Trust (W.G.N., the School of Cancer and Pharmaceutical Sciences, Comprehensive Cancer Centre, King's College London, the Institute of Cancer and Genomic Sciences, University of Birmingham, and the Wellcome Trust Centre for Human Genetics and Oxford NIHR Biomedical Research Centre, University of Oxford, Spanish National Cancer Research Center, Hospital Universitario La Paz (M.P.Z.), Hospital Clinico San Carlos, Instituto de Investigacion Sanitaria del Hospital Clinico San Carlos (M. de la Hoya), Galician Foundation of Genomic Medicine, Instituto de Investigacion Sanitaria de Santiago de Co |
| Paul D P Pharoah | University of Cambridge, MRC Institute of Genetics and Molecular Medicine (A. Campbell, University of Edinburgh, University of Edinburgh Medical School (A. Campbell, Health Services Research, University of Manchester, the NIHR Manchester Biomedical Research Unit (E.F.H.) and the Nightingale Breast Screening Centre, Wythenshawe Hospital (E.F.H., St. Mary's Hospital, Manchester University NHS Foundation Trust (W.G.N., the School of Cancer and Pharmaceutical Sciences, Comprehensive Cancer Centre, King's College London, the Institute of Cancer and Genomic Sciences, University of Birmingham, and the Wellcome Trust Centre for Human Genetics and Oxford NIHR Biomedical Research Centre, University of Oxford, Spanish National Cancer Research Center, Hospital Universitario La Paz (M.P.Z.), Hospital Clinico San Carlos, Instituto de Investigacion Sanitaria del Hospital Clinico San Carlos (M. de la Hoya), Galician Foundation of Genomic Medicine, Instituto de Investigacion Sanitaria de Santiago de Co |
| Georgia Chenevix-Trench | University of Cambridge, MRC Institute of Genetics and Molecular Medicine (A. Campbell, University of Edinburgh, University of Edinburgh Medical School (A. Campbell, Health Services Research, University of Manchester, the NIHR Manchester Biomedical Research Unit (E.F.H.) and the Nightingale Breast Screening Centre, Wythenshawe Hospital (E.F.H., St. Mary's Hospital, Manchester University NHS Foundation Trust (W.G.N., the School of Cancer and Pharmaceutical Sciences, Comprehensive Cancer Centre, King's College London, the Institute of Cancer and Genomic Sciences, University of Birmingham, and the Wellcome Trust Centre for Human Genetics and Oxford NIHR Biomedical Research Centre, University of Oxford, Spanish National Cancer Research Center, Hospital Universitario La Paz (M.P.Z.), Hospital Clinico San Carlos, Instituto de Investigacion Sanitaria del Hospital Clinico San Carlos (M. de la Hoya), Galician Foundation of Genomic Medicine, Instituto de Investigacion Sanitaria de Santiago de Co |
| Georgia Chenevix-Trench | University of Cambridge, MRC Institute of Genetics and Molecular Medicine (A. Campbell, University of Edinburgh, University of Edinburgh Medical School (A. Campbell, Health Services Research, University of Manchester, the NIHR Manchester Biomedical Research Unit (E.F.H.) and the Nightingale Breast Screening Centre, Wythenshawe Hospital (E.F.H., St. Mary's Hospital, Manchester University NHS Foundation Trust (W.G.N., the School of Cancer and Pharmaceutical Sciences, Comprehensive Cancer Centre, King's College London, the Institute of Cancer and Genomic Sciences, University of Birmingham, and the Wellcome Trust Centre for Human Genetics and Oxford NIHR Biomedical Research Centre, University of Oxford, Spanish National Cancer Research Center, Hospital Universitario La Paz (M.P.Z.), Hospital Clinico San Carlos, Instituto de Investigacion Sanitaria del Hospital Clinico San Carlos (M. de la Hoya), Galician Foundation of Genomic Medicine, Instituto de Investigacion Sanitaria de Santiago de Co |
| Javier Ben??tez | University of Cambridge, MRC Institute of Genetics and Molecular Medicine (A. Campbell, University of Edinburgh, University of Edinburgh Medical School (A. Campbell, Health Services Research, University of Manchester, the NIHR Manchester Biomedical Research Unit (E.F.H.) and the Nightingale Breast Screening Centre, Wythenshawe Hospital (E.F.H., St. Mary's Hospital, Manchester University NHS Foundation Trust (W.G.N., the School of Cancer and Pharmaceutical Sciences, Comprehensive Cancer Centre, King's College London, the Institute of Cancer and Genomic Sciences, University of Birmingham, and the Wellcome Trust Centre for Human Genetics and Oxford NIHR Biomedical Research Centre, University of Oxford, Spanish National Cancer Research Center, Hospital Universitario La Paz (M.P.Z.), Hospital Clinico San Carlos, Instituto de Investigacion Sanitaria del Hospital Clinico San Carlos (M. de la Hoya), Galician Foundation of Genomic Medicine, Instituto de Investigacion Sanitaria de Santiago de Co |
| Alison M Dunning | University of Cambridge, MRC Institute of Genetics and Molecular Medicine (A. Campbell, University of Edinburgh, University of Edinburgh Medical School (A. Campbell, Health Services Research, University of Manchester, the NIHR Manchester Biomedical Research Unit (E.F.H.) and the Nightingale Breast Screening Centre, Wythenshawe Hospital (E.F.H., St. Mary's Hospital, Manchester University NHS Foundation Trust (W.G.N., the School of Cancer and Pharmaceutical Sciences, Comprehensive Cancer Centre, King's College London, the Institute of Cancer and Genomic Sciences, University of Birmingham, and the Wellcome Trust Centre for Human Genetics and Oxford NIHR Biomedical Research Centre, University of Oxford, Spanish National Cancer Research Center, Hospital Universitario La Paz (M.P.Z.), Hospital Clinico San Carlos, Instituto de Investigacion Sanitaria del Hospital Clinico San Carlos (M. de la Hoya), Galician Foundation of Genomic Medicine, Instituto de Investigacion Sanitaria de Santiago de Co |
| Douglas F Easton | University of Cambridge, MRC Institute of Genetics and Molecular Medicine (A. Campbell, University of Edinburgh, University of Edinburgh Medical School (A. Campbell, Health Services Research, University of Manchester, the NIHR Manchester Biomedical Research Unit (E.F.H.) and the Nightingale Breast Screening Centre, Wythenshawe Hospital (E.F.H., St. Mary's Hospital, Manchester University NHS Foundation Trust (W.G.N., the School of Cancer and Pharmaceutical Sciences, Comprehensive Cancer Centre, King's College London, the Institute of Cancer and Genomic Sciences, University of Birmingham, and the Wellcome Trust Centre for Human Genetics and Oxford NIHR Biomedical Research Centre, University of Oxford, Spanish National Cancer Research Center, Hospital Universitario La Paz (M.P.Z.), Hospital Clinico San Carlos, Instituto de Investigacion Sanitaria del Hospital Clinico San Carlos (M. de la Hoya), Galician Foundation of Genomic Medicine, Instituto de Investigacion Sanitaria de Santiago de Co |